STK16以c-MYC信号依赖的方式促进了结直肠癌的进展
Li Peng1, Liu Guangshi1, Lai Bijiang Wusman1
1Gastrointestinal Surgery department, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi City, Xinjiang Province, China.
Molecular medicine (Cambridge, Mass.)
|April 15, 2024
概括
通过酸化,STK16通过稳定蛋白c-MYC促进结直肠癌. 抑制STK16可以降低瘤生长和c-MYC水平,从而确定STK16是结直肠癌的潜在治疗标.
科学领域:
- 分子瘤学分子瘤学
- 癌症生物学 癌症生物学
- 信号传导传导是指信号的传导.
背景情况:
- 结肠直肠癌 (CRC) 是全球领先的健康问题,需要对其发育机制有更深入的了解.
- 虽然STK16在癌症中的作用尚未得到充分研究,但c-MYC是已知的致癌驱动因素,尽管直接抑制具有挑战性.
- 研究重点是调节c-MYC表达水平作为治疗策略.
研究的目的:
- 研究STK16在结直肠癌进展中的作用.
- 阐明在CRC中将STK16和c-MYC信号连接在一起的分子机制.
- 评估STK16作为CRC的潜在治疗点.
主要方法:
- 使用免疫斑块,免疫沉和RT-PCR进行蛋白质和mRNA表达分析.
- 评估癌细胞的扩散,迁移,入侵和殖民地形成.
- 在体外和体内实验中探索STK16-c-MYC信号轴.
主要成果:
- STK16积极调节结直肠癌的进展.
- 在血清452处,STK16酸化c-MYC,防止其通过ubiquitin-proteasome路径降解.
- STK16抑制 (遗传或药理) 在体内显著降低CRC增殖和c-MYC表达.
结论:
- 在S452的STK16介导的c-MYC酸化稳定了蛋白,并促进了CRC的生长.
- 准STK16为抑制结直肠癌提供了一个有希望的策略.
- STK16被确定为结直肠癌治疗的潜在治疗标.
相关概念视频
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K


